𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with cisplatin (CDDP) and epirubicin (EPI) including medroxyprogesterone acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer

✍ Scribed by G. Mantovani; A. Macciò; P. Lai; E. Massa; M.C. Mudu; G. Manca; C. Mulas; D. Massa; G. Succu; R. Versace


Book ID
117667970
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
163 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES